137 related articles for article (PubMed ID: 7820258)
1. High-performance liquid chromatographic determination of spironolactone and its major metabolite canrenone in urine using ultraviolet detection and column-switching.
Herráez-Hernández R; Soriano-Vega E; Campíns-Falcó P
J Chromatogr B Biomed Appl; 1994 Aug; 658(2):303-10. PubMed ID: 7820258
[TBL] [Abstract][Full Text] [Related]
2. Determination of canrenone, the major metabolite of spironolactone, in plasma and urine by high-performance liquid chromatography.
Krause W; Karras J; Jakobs U
J Chromatogr; 1983 Oct; 277():191-9. PubMed ID: 6643605
[TBL] [Abstract][Full Text] [Related]
3. High-performance liquid chromatographic determination of spironolactone and its metabolites in human biological fluids after solid-phase extraction.
Varin F; The Minh Tu; Benoît F; Villeneuve JP; Théorêt Y
J Chromatogr; 1992 Feb; 574(1):57-64. PubMed ID: 1629288
[TBL] [Abstract][Full Text] [Related]
4. A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples.
Avataneo V; De Nicolò A; Rabbia F; Sciandra M; Tosello F; Cusato J; Perlo E; Fatiguso G; Allegra S; Favata F; Mulatero P; Veglio F; Di Perri G; D'Avolio A
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):29-35. PubMed ID: 30165207
[TBL] [Abstract][Full Text] [Related]
5. Application of column-switching techniques to the determination of medium polarity drugs: determination of acetazolamide in urine.
Campíns-Falcó P; Herráez-Hernández R; Sevillano-Cabeza A
J Chromatogr B Biomed Appl; 1994 Mar; 654(1):85-90. PubMed ID: 8004247
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous separation and rapid determination of spironolactone and its metabolite canrenone in different pharmaceutical formulations and urinary matrices by capillary zone electrophoresis.
Li L; Huang Y; Zhao W; Zhang G; Zhang H; Chen A
J Sep Sci; 2016 Jul; 39(14):2869-75. PubMed ID: 27257119
[TBL] [Abstract][Full Text] [Related]
7. Use of partial least-squares regression for multicomponent determinations based on kinetic spectrofluorimetric data. Simultaneous determination of canrenone and spironolactone in urine.
Hernández O; Martín E; Jiménez F; Jiménez AI; Arias JJ
Analyst; 2000 Jun; 125(6):1159-65. PubMed ID: 10932858
[TBL] [Abstract][Full Text] [Related]
8. Eco-friendly solvent bar microextraction based on a natural deep eutectic solvent and multivariate optimization for simultaneous determination of spironolactone and canrenone in urine and plasma samples.
Al-Hashimi NN; Alfattah HA; El-Sheikh AH; Hamed SH; Abu Safieh KA
Environ Sci Pollut Res Int; 2024 Jan; 31(2):3031-3043. PubMed ID: 38079037
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of spironolactone and its metabolites in human plasma.
Jankowski A; Skorek-Jankowska A; Lamparczyk H
J Pharm Biomed Anal; 1996 Jun; 14(8-10):1359-65. PubMed ID: 8818057
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of spironolactone and its active metabolite canrenone in human plasma by HPLC-APCI-MS.
Dong H; Xu F; Zhang Z; Tian Y; Chen Y
J Mass Spectrom; 2006 Apr; 41(4):477-86. PubMed ID: 16541392
[TBL] [Abstract][Full Text] [Related]
11. Determination of propafenone and its main metabolite 5-hydroxypropafenone in human serum with direct injection into a column-switching chromatographic system.
Kubalec P; Brandsteterová E
J Chromatogr B Biomed Sci Appl; 1999 Apr; 726(1-2):211-8. PubMed ID: 10348188
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of HPTLC and green HPLC methods for determination of furosemide, spironolactone and canrenone, in pure forms, tablets and spiked human plasma.
Naguib IA; Abdelaleem EA; Emam AA; Ali NW; Abdallah FF
Biomed Chromatogr; 2018 Oct; 32(10):e4304. PubMed ID: 29855049
[TBL] [Abstract][Full Text] [Related]
13. Determination of the serum concentration of spironolactone and its metabolites by high-performance liquid chromatography.
Overdiek JW; Hermens WA; Merkus FW
J Chromatogr; 1985 Jun; 341(2):279-85. PubMed ID: 4030980
[TBL] [Abstract][Full Text] [Related]
14. Conventional and micellar liquid chromatography method development for danazol and validation in capsules.
Gonzalo-Lumbreras R; Izquierdo-Hornillos R
J Pharm Biomed Anal; 2003 Jul; 32(3):433-9. PubMed ID: 14565547
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic determination of canrenone, a major metabolite of spironolactone, in body fluids.
Neurath GB; Ambrosius D
J Chromatogr; 1979 Jun; 163(2):230-5. PubMed ID: 541378
[No Abstract] [Full Text] [Related]
16. Amphetamine and methamphetamine determination in urine by reversed-phase high-performance liquid chromatography with sodium 1,2-naphthoquinone 4-sulfonate as derivatizing agent and solid-phase extraction for sample clean-up.
Molíns Legua C; Campíns Falcó P; Sevillano Cabeza A
J Chromatogr B Biomed Appl; 1995 Oct; 672(1):81-8. PubMed ID: 8590941
[TBL] [Abstract][Full Text] [Related]
17. [Determination of captopril in plasma and urine by high-performance liquid chromatography with column switching].
Tian WR; Gao S; Wang SX
Yao Xue Xue Bao; 1992; 27(8):613-7. PubMed ID: 1481679
[TBL] [Abstract][Full Text] [Related]
18. [Column-switching high-performance liquid chromatographic method for the determination of morphine and O6-monoacetylmorphine in urine].
Zhang YR; Wang R; Zhang CG
Fa Yi Xue Za Zhi; 2002 May; 18(2):89-91. PubMed ID: 12596597
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive screening procedure for diuretics in urine by high-performance liquid chromatography.
Cooper SF; Massé R; Dugal R
J Chromatogr; 1989 Apr; 489(1):65-88. PubMed ID: 2745658
[TBL] [Abstract][Full Text] [Related]
20. Analytical issues in HPLC/MS/MS simultaneous assay of furosemide, spironolactone and canrenone in human plasma samples.
Sora DI; Udrescu S; Albu F; David V; Medvedovici A
J Pharm Biomed Anal; 2010 Sep; 52(5):734-40. PubMed ID: 20307949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
